Found 68 matching trials
Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV PHASE2 Cyclosporine A (CsA) is a common long-term treatment used to inhibit the im...
Show More Location
University of Minnesota, ACTU
Learn More & Join Trial
A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects PHASE1 This study will be a 2-part, open-label, single-center relative bioavailabi...
Show More Learn More & Join Trial
A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe PHASE2 Open-label study of a regimen of antiretrovirals for the treatment of AIDS-...
Show More Location
University of Zimbabwe College of Health Sciences Department of Medicine
Learn More & Join Trial
Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients PHASE3 To evaluate the therapeutic equivalence between the two arms of treatment i...
Show More Location
Institute of Infections and Tropical Diseases University of Brescia
Learn More & Join Trial
Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children PHASE1 Cross-over 28 week study of the plasma pharmacokinetic profiles of twice da...
Show More Location
Great Ormond Street Hospital
Learn More & Join Trial
Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids N/A More than 150,000 babies became infected with HIV in 2015 alone. When HIV d...
Show More Location
St. Monica's Hospital
Learn More & Join Trial
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments PHASE4 The goal of this clinical study is to provide continued access to the study...
Show More Learn More & Join Trial
Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants PHASE1 This is a two-part, open-label, randomized, crossover study in healthy subj...
Show More Learn More & Join Trial
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily PHASE3 The purpose of this trial is to assess the non-inferior antiviral activity ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer. PHASE2 The primary objetive is to assess the capacity of the RAD51-foci score to p...
Show More Location
H Clinic de Barcelona
Learn More & Join Trial